Featured

The shift to remote work has exposed the shortcomings of virtual private networks and led to a growing number of PE firms embracing the “zero trust” model.

Regulated ’40 Act funds and business development companies are turning to credit lines for greater flexibility in handling liquidity requirements. Khizer Ahmed runs Hedgewood Capital Partners, a New York-based fund finance advisory business. He has spent a large portion of his career in investment banking, and he now assists borrowers on the finer points of […]

Charly Weinstein discusses the accounting firm's recent deal with TowerBrook, and how the business's new 'alternative practice structure' could shake up the industry.

Whether it’s tenders, intervals, evergreens or hybrids, the private funds industry is seeing a re-emergence of novel fund structures. We spoke to managers and service providers trying to tap a growing base of investors.

'Plan ahead' is the byword for CFOs in charge of managing subscription credit lines and bank relationships, as higher staff turnover and changes in risk appetite at lenders have accompanied an evolution into an otherwise more transparent market.

A House bill, as currently written, came as a surprise to the market, as other regulatory, inflation and competitive headwinds abound in private equity. But Fall Forum panelists kept their chins up about the future.

Panelists at the CFOs & COOs Forum spoke of how the standard GP structure is straining under the weight of value yet to be realized.

Spurred by the prospect of rising taxes, US dealflow is super-hot, said participants at the CFOs & COOs Forum. But there are caveats.

The pandemic caused a major increase in reporting demands for firms. However, attendees at the CFOs & COOs Forum spoke of how that demand had resulted in greatly improved processes.

Navneet Govil, CFO of Softbank’s Vision Fund unit, spoke at the CFOs & COOs Forum about the firm’s network, designed to facilitate knowledge sharing among portfolio company CFOs, and its recent partnership with IonQ.